Skip to main content
. 2023 Jul 10;13(7):e070616. doi: 10.1136/bmjopen-2022-070616

Table 3.

Study schedule

Scheduling Screening and enrolment Baseline and treatment day 1 Treatment day 2* 48 hours 1 week 3 weeks 6 weeks 12 weeks
3 weeks before baseline 3 weeks after enrolment 1 day after baseline 2 days after baseline 1 week after baseline 3 weeks after baseline 6 weeks after baseline 12 weeks after baseline
Visit type Clinic Clinic Clinic Phone call Phone call Phone call Clinic Clinic
Eligibility screen
Informed consent
FMT treatment
Adverse events
Tolerability questionnaire
Background questionnaire
Eating disorder symptoms (EDEQ)66
Depression symptoms (PHQ-9)60
Anxiety symptoms (GAD-7)67
Stool sample
Blood sample
Whole-body composition scan (DXA)

*Study timeline is based on a 2 day treatment schedule. If a participant decides to spread their treatment over four consecutive days, the tolerability questionnaire will be administered on the final day of treatment (day 4) and the 48 hour phone call will be 24 hours after the final dose of capsules.

DXA, dual-energy X-ray absorptiometry; EDEQ, Eating Disorder Examination Questionnaire; FMT, faecal microbiome transfer; GAD-7, General Anxiety Disorder 7-item scale; PHQ-9, Patient Health Questionnaire 9.